U.S., June 24 -- ClinicalTrials.gov registry received information related to the study (NCT07664124) titled 'Digital Monitoring of Upper Limb Function in Non-Ambulant DMD' on June 15.
Brief Summary: Duchenne Muscular Dystrophy (DMD) is a rare genetic disorder caused by the absence of dystrophin, leading to progressive muscle degeneration. Symptoms typically begin in early childhood and result in loss of ambulation by early adolescence, followed by cardiorespiratory complications. Although early treatment, including corticosteroids and emerging therapies, can slow disease progression, sensitive tools to monitor functional decline-particularly in non-ambulant patients-remain limited.
Current assessments rely primarily on clinical scales and...